Chemoinformaics analysis of 6,10-Dimethyl-bicyclo[4.4.0]dec-10-en-3-one
| Molecular Weight | 178.275 | nRot | 0 |
| Heavy Atom Molecular Weight | 160.131 | nRig | 12 |
| Exact Molecular Weight | 178.136 | nRing | 2 |
| Solubility: LogS | -2.786 | nHRing | 0 |
| Solubility: LogP | 2.757 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 32.8443 |
| nHD | 0 | BPOL | 18.9257 |
| QED | 0.52 |
| Synth | 3.551 |
| Natural Product Likeliness | 2.269 |
| NR-PPAR-gamma | 0.958 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.751 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.644 |
| MDCK | 0.0000185 |
| BBB | 0.963 |
| PPB | 0.825147 |
| VDSS | 1.443 |
| FU | 0.117958 |
| CYP1A2-inh | 0.092 |
| CYP1A2-sub | 0.484 |
| CYP2c19-inh | 0.209 |
| CYP2c19-sub | 0.842 |
| CYP2c9-inh | 0.106 |
| CYP2c9-sub | 0.5 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.215 |
| CYP3a4-inh | 0.098 |
| CYP3a4-sub | 0.347 |
| CL | 9.81 |
| T12 | 0.827 |
| hERG | 0.009 |
| Ames | 0.458 |
| ROA | 0.1 |
| SkinSen | 0.468 |
| Carcinogencity | 0.2 |
| EI | 0.979 |
| Respiratory | 0.958 |
| NR-Aromatase | 0.037 |
| Antiviral | No |
| Prediction | 0.688657 |